Evidence map›Paper›PMID 41011780›Full record

ArticlePathogens (Basel, Switzerland)2025

Global Burden and Incidence Trends in Cancers Associated with Human Papillomavirus Infection: A Population-Based Systematic Study.

Xiaojun Meng, Bolin Yang, Hanlu Yin, Jibiao Chen, Wenjuan Ma, Zhuping Xu, Yuan Shen

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiaojun MengThe Affiliated Wuxi Center for Disease Control and Prevention of Nanjing Medical University, Wuxi 214023, China.
Bolin YangThe Affiliated Wuxi Center for Disease Control and Prevention of Nanjing Medical University, Wuxi 214023, China.
Hanlu YinThe Affiliated Wuxi Center for Disease Control and Prevention of Nanjing Medical University, Wuxi 214023, China.
Jibiao ChenThe Affiliated Wuxi Center for Disease Control and Prevention of Nanjing Medical University, Wuxi 214023, China.
Wenjuan MaThe Affiliated Wuxi Center for Disease Control and Prevention of Nanjing Medical University, Wuxi 214023, China.
Zhuping XuThe Affiliated Wuxi Center for Disease Control and Prevention of Nanjing Medical University, Wuxi 214023, China.
Yuan ShenThe Affiliated Wuxi Center for Disease Control and Prevention of Nanjing Medical University, Wuxi 214023, China.

Funding

Wuxi Health Commission BJ2023097, FZXK2021010, P202314
6 · The paper itself

Abstract

backgroundHuman papillomavirus (HPV) is responsible for a substantial fraction of anogenital and head and neck cancers (HNC). HPV-related cancers cause a heavy burden globally, with disparities across different cancers. We aimed to present an up-to-date global view of the patterns and incidence trends among HPV-related cancers.

methodsWe collected data on HPV-related cancers from the GLOBOCAN 2022 database and the Cancer Incidence in Five Continents plus Compendium. Age-standardized incidence and mortality rate (ASIR and ASMR) were calculated to estimate the cancer burden. Spearman's correlation tests were used to evaluate the associations with the Human Development Index (HDI). Joinpoint regression was conducted to evaluate the incidence trends in ASIR.

resultsIn 2022, 1,505,394 HPV-related cancer cases and 755,303 deaths were newly estimated worldwide, corresponding to an overall ASIR and ASMR of 20.9 and 10.2 per 100,000 people, respectively. Africa had the highest ASIR and ASMR compared with Asia, accounting for the most new cases and deaths. The primary cause was cervical cancer (ASIR 14.1 per 100,000 people); however, HNC exhibited the largest number of cases (685,204 cases). The total rates of HPV-related cancers were 1.3 times higher for ASIR and nearly three times higher for ASMR in low-HDI countries than in very high-HDI countries. A decreasing trend was observed for the ASIR of cervical cancer in most studied countries, compared to the increasing trends in HNC in females and anal cancer in both sexes.

conclusionsThe global burden and trends of HPV-related cancers vary significantly among different cancer types according to region and sex. Particularly, cervical, HNC, and anal cancers should attract global attention. However, specific cancer types contributing to the heaviest burden should be identified at the country level to adjust resource allocation and improve access to quality health services.

Indexed as

Head and Neck NeoplasmsNeoplasmsPapillomavirus InfectionsAdultAgedAnus NeoplasmsFemaleGlobal Burden of DiseaseGlobal HealthHumansIncidenceMaleMiddle AgedPapillomaviridaeUterine Cervical Neoplasmsburdencancerglobal trendhuman papillomavirusincidence

Identifiers

PMID41011780
PMCPMC12472360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.